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Michigan Opioid Legislation – Act No. 251:
The Effort to End the Opioid Epidemic
Nicolette G. Keller
Grand Valley State University
Abstract
There is without a doubt an opioid consumption and subsequent opioid overdose
epidemic currently in the United States. With the formation of any epidemic,
governmental policies are created and enacted to combat and end the epidemic. Many
different state and federal policy solutions have been proposed. This paper focuses on
Michigan’s attempt at reducing the opioid epidemic with Policy Act No. 251 in Public
Acts of 2017 of Michigan (2017 PA 251). According to 2017 PA 251, a prescriber
shall not prescribe his/her patient more than a 7-day supply of an opioid within a
7-day period if the prescriber is treating the patient for acute pain. In order to analyze
if prescription limitations benefits outweigh the disadvantages, the policy beneficiaries,
targets, instruments and outcomes are identified. Based upon the gathered information
three areas are recommended for policy improvement. Michigan is not the only state
suffering from the opioid epidemic. Other state opioid laws and mitigation models are
identified and analyzed to show that not one solution on its own will be likely to solve the
opioid epidemic. States must learn from each other’s successes and failures and work as a
nation to solve the prescription opioid epidemic that kills on average 17,000 Americans
a year (National Institute on Drug Abuse, 2019).
Keywords: opioid, prescription, policy, epidemic, prescriber, supply,
limitations
Introduction
Policy Act No. 251 in Public Acts of 2017 of Michigan (2017 PA 251)
is an act to amend 1978 PA 368 which specifically amends section 7333
and adds section 7333b. 2017 PA 251 is one bill of a package of 10 bills to
decrease the state of Michigan’s opioid dependence and substance abuse
problem. According to the Centers for Disease Control and Prevention
(2018), “In 2017, the number of overdose deaths involving opioids
(including prescription opioids and illegal opioids like heroin and illicitly
manufactured fentanyl) was 6 times higher than in 1999” (cdc.gov). In
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Michigan, according to Michigan.gov (2019), there is a “17 times increase in
overdose deaths in Michigan from the span of 1999-2016, from 99 deaths
to 1,699 deaths”. Michigan providers wrote 96.1 opioid prescriptions per
100 persons (9.5 million prescriptions) in 2015 compared to average U.S.
rate of 70 opioid prescriptions per 100 persons also in 2015 (National
Institute on Drug Abuse, 2018). Michigan providers have been prescribing
opioids at an alarmingly high rate compared to the rest of the country.
According to guidelines presented by the Centers for Disease Control
and Prevention in 2016:
Long-term opioid use often begins with treatment of acute pain.
When opioids are used for acute pain, clinicians should prescribe
the lowest effective dose of immediate-release opioids and should
prescribe no greater quantity than needed for the expected duration
of pain severe enough to require opioids. Three days or less will
often be sufficient; more than seven days will rarely be needed (cdc.
gov).
The state of Michigan’s legislation is attempting to decrease the
number of opioid overdoses with 2017 PA 251. According to 2017 PA
251, a prescriber shall not prescribe his/her patient more than a 7-day
supply of an opioid within a 7-day period if the prescriber is treating the
patient for acute pain. The legislation provides a definition by the Michigan
Health Code for acute pain as it pertains to the prescription of opioid pain
medication. Another amendment included in 2017 PA 251 is the ability for
pharmacists to partially fill in increments prescriptions for a schedule IIcontrolled substance.
2017 PA 251 Analysis
In order to analyze the positive or negative impact that 2017 PA 251
has had on the opioid crisis in the state of Michigan, certain components
must be identified. These components include the law’s intended:
beneficiaries, targets, instruments and outcomes. With these components
identified, 2017 PA 251 can be analyzed to determine if the benefits
outweigh the disadvantages, if the law achieves its desired outcomes and if
anything can be changed to enhance the intended positive outcomes. An
analysis of what other states in the United States are enacting into law to
combat their specific opioid addiction issues should assist in identifying a
strong model to mitigate Michigan’s many opioid addiction issues.
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Beneficiaries
2017 PA 251 has many groups of people that it benefits including
medication prescribers (physicians, physician assistants, nurse practitioners
and dentists), patients and insurance companies. Each group has a shared
interest in eliminating the current opioid epidemic, and this law benefits
each group in unique ways.
Opioid Medication Prescribers
2017 PA 251 provides direct legislation for state of Michigan licensed
physicians, physician assistants, nurse practitioners and dentists to follow
for opioid medication. Physicians can reference a patient’s electronic
medical record to see their prescription history and if the patient has a
long history of utilizing opioid medication for acute injuries, this law now
provides a reason to only prescribe the 7-day supply amount. Essentially,
the law provides a scapegoat for prescribers to place “the blame” on the
government and not the prescriber when the prescriber only wants to
prescribe the minimum amount of opioid medication necessary. The law
also strengthens the patient-physician relationship due to the patient’s
apparent need for a refill where follow-up communication post-initial
visit is required. 2017 PA 251 also has the potential to reduce liability and
malpractice lawsuits for medication prescribers.
Patients
The main goal of 2017 PA 251 benefits the overall Michigan patient
population with the aim of reducing patient dependence on opioid
medication that leads to patient opioid overdose and death. The legislation
limits the patient’s opportunity to become addicted to the prescription
opioids that are prescribed for acute pain. The legislation does not intend to
interfere with prescriptions meant to treat chronic pain. Patients also benefit
in the addition of 30 days to partially fill prescriptions increasing from 60
days from prescription date to 90 days. This potentially helps the patient
with affordability of their opioid prescriptions and helps to limit a patient’s
likelihood of overdose due to not receiving the full amount of medication
at one time.
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Health Insurance Providers
Health insurance providers both public and private, benefit from 2017
PA 251 because of the restriction of prescribing opioid medication to the
7-day amount. The smaller number of opioids a patient is prescribed will
save insurance companies the cost of paying for unused opioid medication.
Health insurance companies will likely restructure policies surrounding
utilization management of opioid prescriptions. Health insurers will feel
the positive pressure to do their part in reducing the opioid epidemic by
recommending comprehensive strategies to improve their members chronic
pain rather than approving large amounts of opioid medication.
Pharmacies
Pharmacies and pharmacists benefit from 2017 PA 251. Pharmacies
may not have to order and stock as much opioids, and pharmacies may be
less likely to run out of opioid stock. The legislation allows the pharmacist
more flexibility to partially fill in increments prescriptions for a schedule
II-controlled substance by increasing the prescription fill date from 60 days
to 90 days. (Haddad, 2018)
Law Enforcement and First Responders
Michigan state and local community law enforcement benefit from the
main outcome that 2017 PA 251 aims to produce, reduced opioid overdoses
and death. According to the Bloomberg American Health Initiative (n.d.),
“Law enforcement officers are on the front lines of addressing this
nationwide crisis. They are often the first to arrive on the scene of an
overdose.” The fewer number of opioid overdoses will result in fewer law
enforcement responses allowing law enforcement more time and resources
to focus on other state and local concerns. Opioid addiction has a greater
tendency to lead to heroin and illicit fentanyl use. Reducing a Michigan
resident’s opioid intake will reduce their inherent risk for opioid addiction
which will reduce the number of new heroin addicts that law enforcement
will have to deal with.
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Other Beneficiaries
Other beneficiaries of 2017 PA 251 include spouses, children & pets
residing in households who have Michigan residents consuming opioids
for acute pain.According to staff at the Mayo Clinic, dependence on
prescription opioids sharply increases after just five days of use. “In fact,
most people who misuse prescription painkillers report getting them from
a family member or friend.” (Mayo Clinic, n.d.) If opioid prescription is
restricted to a 7-day supply, it is more likely the patient with acute pain will
utilize most or all of the opioid medication which then decreases the chance
of family or children opioid consumption.
Targets
The targets of the 2017 PA 251 legislation include state of Michigan
medication prescribers, Michigan patients, and pharmacies located in the
state of Michigan. Medication prescribers are at the center of the legislation
as they are the group responsible for prescribing the lawful amount of
opioid medication. According to Dineen & DuBois (2016), “Physicians
bear responsibility for careful and conscientious prescribing, which includes
patient assessment, communication, and education”. Physicians and all
medication prescribers are held to a higher standard to learn about their
prescribing habits and the opioid consumption of their patients. Patients
are also held to a higher standard to limit the opioid medication they receive
to control and reduce their personal opioid medication dependencies.
Just as 2017 PA 251 targets physicians and patients, this legislation
targets pharmacies and health insurance companies for their role upholding
the lawful amount of opioid medication provided to the patient. Insurance
companies in particular have a responsibility to perform evidence-based
utilization management for their members/beneficiaries. According to
Johns Hopkins Bloomberg School of Public Health (2018), “There are
three types of common “utilization management”—quantity limits, step
therapy and prior authorization.” 2017 PA 251 enforces health insurance
companies in the state of Michigan to implement utilization management
in the form of quantity limits. 2017 PA 251 targets health insurance
companies to use evidence-based, proper utilization management with
opioid prescriptions.
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Instruments
The main instrument utilized in 2017 PA 251 is creating and enacting
a rule that prescribers must only prescribe a seven-day supply of pain
medication for acute pain in the state of Michigan. In order to prescribe
a seven-day supply ofopioids, the prescriber must check a patient’s past
prescription use on the Michigan Automated Prescription System (MAPS).
According to the Michigan Department of Licensing and Regulatory
Affairs (LARA), “MAPS is used to track controlled substances, schedules
2-5 drugs. It is a tool used by prescribers and dispensers to assess patient
risk and is also used to prevent drug abuse and diversion at the prescriber,
pharmacy, and patient levels.” (Michigan.gov, 2019) In addition to MAPS, a
prescriber should reference the patients electronic medical record for past
prescription use. Medication prescribers face punitive consequences, such as
licensing disciplinary actions, for prescribing more than the lawful amount
in acute care cases.
Outcomes
2017 PA 251 has clear intended outcomes and also produces both
positive and negative unintended outcomes. The benefits that 2017 PA 251
produces from its intended outcomes should far outweigh the negative
outcomes that are not accounted for.
Intended Outcomes
According to the U.S. Department of Health and Human Services
(2017), “Nearly 80% of heroin users reported misusing prescription opioids
prior to heroin.” 2017 PA 251 intends to reduce and eliminate opioid
addiction, opioid overdose and death and heroin use by limiting the number
of prescribed opioids to a 7-day supply.
An important purpose of 2017 PA 251 is to inform opioid prescribers
of their prescribing habits and the opioid consumption habits of their
patients. “U-M opioid researchers Amy Bohnert, Ph.D., and Pooja Lagisetty,
M.D., urge hospital-based doctors to take seriously the responsibility of
addressing signs of opioid misuse, even when patients are still inpatients.”
(Gavin, 2017) While utilizing MAPS in order to prescribe a full 7-day
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supply of opioids, a Michigan licensed medication prescriber will take more
responsibility to control a patients’ risk in abusing medication.
Unintended Outcomes
According to Norton (n.d.) and the Library of Economics and Liberty,
“The law of unintended consequences, often cited but rarely defined, is
that actions of people—and especially of government—always have effects
that are unanticipated or unintended.” 2017 PA 251 provides a clear and
concise solution to reduce the opioid epidemic, but the law has had and will
continue to have unintended outcomes that are both positive and negative
in nature.
Positive. An unintended positive outcome of the 7-day prescription
opioid limit is that it forces Michigan residents to deal with and manage
pain in different ways rather than relying on opioid medications. According
to Ory (2018), “Daily opioid use in the U.S. is the highest in the world, with
an estimated one daily dose prescribed for every 20 people”. Ory
(2018) continues to explain that other countries such as in Europe, it’s less
common to dispense opioids for non- cancer related pain such as chronic
back or musculoskeletal pain due to the tighter regulations and restrictions
on advertisements. Michigan’s increased regulations on the limit of opioid
prescriptions should reduce the dependence on opioids and enhance other
ways to manage pain such as with non-pharmacologic therapies.
A result of the opioid prescription limitations is the focus on nonpharmacologic therapies such as physical therapy. According to the Centers
for Disease Control and Prevention (CDC) (2016), opioids come with too
many side effects and are too addictive to be a first-choice treatment for
acute and chronic pain. The CDC recommends physical therapy as one
of many proven alternatives to opioid therapy. Alice Bell PT, DPT, states,
“Across the profession (physical therapy) we’re seeing more and more
patients who are accessing physical therapy before opioids are prescribed,
or who’ve been on opioids but realize they aren’t helping to treat or manage
their underlying conditions” (Hayhurst, 2018). Physicians can and should
shift their treatment plans of care to a more healing approach, rather than
going for the instant cure of pain removal from opioid medication.
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Negative. As with any new law or amendment to law, the law’s
implementation phase can cause confusion between the law’s beneficiaries,
targets and others involved in the process. Although 2017 PA 251 focuses
on patients with acute pain, chronic pain patients initially may have issues
receiving their opioid medication due to an administration or prescriber’s
misinterpretation of the law. Prescriber’s may fear not correctly following
the rules and regulations of 2017 PA 251 and feel pressure from their
administration to administer the lowest opioid dosage feasible to all of their
patients. Miscommunication and misinterpretation of 2017 PA 251 can
lead to advocacy groups such as The Alliance for the Treatment of
Intractable Pain advocating for the removal of the opioid prescription limit
due to its potential backlash in the chronic care community.
Miscommunication can occur between a patient, their provider and
their insurance company. According to Greene (2018), “Health insurers are
using the laws to inappropriately deny or delay prescriptions, sometimes
even for patients with cancer and terminal illness”. In order to avoid
this issue, alignment must occur and be clear in policies with providers,
insurance companies and the law.
In rare, severe cases patients who run out of their 7-day opioid
medication and require more opioid medication may resort to visiting their
local hospital’s emergency room to manage their pain. Patients may also
turn to purchasing opioids illegally and in extreme cases resort to heroin to
receive the same effects that their opioid prescription would have provided
(Greene, 2018).
Recommendations for Policy Improvement
2017 PA 251 is not perfect a perfect piece of legislation. Legislators
must understand that in order to modify and improve the law’s intended
outcomes, it is important to work with the law’s targets to receive
comments and feedback. The physician target group must be brought to
the table to discuss 2017 PA 251 and all ten bills included in Michigan’s
legislature attempt to control the opioid epidemic.
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Legislation Language
According to Greene (2018), physicians must learn to be patient and
avoid reacting to resistance to change versus resistance to unnecessary
or non-value-adding regulation. Michigan legislature should work with
physicians and other medication prescribers to better define and describe
the circumstances and parameters that which justify prescribing beyond a
seven-day supply of opioid medication for acute pain. Language should
be written into 2017 PA 251 that assists physicians and opioid medication
prescribers to follow correct steps and delineates situations that create
the justified need for an increased opioid supply. The added language will
reduce the medication prescriber’s fear of punitive action if they prescribe
more than a 7-day supply because they will have followed the rules set forth
in the law to do so.
Data Collection
Hospitals and physician groups in Michigan should be able to utilize
MAPS, the instrument used to track a patients past opioid medication history, to perform studies on the success rate of a 7-day supply prescription.
Data collection should be strongly encouraged for hospitals to complete
to see if 2017 PA 251 will make an impactful difference in decreasing the
number of opioid overdoses. Studies and data collection on opioid prescriptions can assist in proving the value 2017 PA 251 and if it is creating
the outcomes it was intended to. Gavin (2018) details a study by a University of Michigan surgical research team in which they discovered that on
average, patients took only 27 percent of all opioids prescribed to them.
But for every 10 additional pills prescribed, patients took five of them. This
study is one piece of proof that limiting a prescription to a 7-day supply
will decrease and even eliminate the over- consumption of opioid medication.
Education of Benefits
The Department of Licensing and Regulatory Affairs (LARA) and
the Michigan Department of Health and Human Services (DHHS) should
dedicate two to five years to gather in-depth data regarding the patient outcomes and resulting rate of opioid overdoses after implementation of 2017
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PA 251. Physicians, health administration leaders and other regulatory agencies will require evidence-based data and information to see the benefits
that the legislation can provide. Education on the benefits of 2017 PA 251
should be distributed to both physicians and leaders in Michigan healthcare
facilities to provide visual proof of the positive effect that the legislation
has provided. The education should further emphasize the importance of
opioid prescription limitations and clearly demonstrate that compliance
with the legislation has made a positive impact on the reduction of opioid
overdoses.
State vs. Federal Legislation
Current federal law on the prescription of opioids limits prescriptions
to a 30+ day supply which is considerably more lenient than the strict 7-day
supply rule in Michigan. Data collection and the completion of studies are
imperative to track the success and intended outcomes of 2017 PA 251 in
order to influence change and modification at the federal level. The country is desperately looking for thebest solution to solve the opioid epidemic,
and with data to prove it, Michigan legislation can provide the necessary
solutions.
States with Similar Opioid Legislation
In order to improve Michigan’s response to the opioid epidemic,
LARA and the Michigan DHHS can look outside of Michigan’s state
lines to research what other state legislators are enacting into their opioid
legislation. According to Athena Health (2019), at least 33 states currently
have day supply limits for written prescriptions and/or schedule II drugs
unrelated to extenuating (chronic) circumstances.
Florida
According to Rutkow et al. (2015), “From 2003 to 2009, prescription
drug overdose deaths in Florida increased more than 80%”. Florida
suffered extensively from the over prescription of opioids and therefore
has enacted strict laws to prevent opioid over prescription. On July 1st,
2018 Florida’s governor enacted into legislation 2018-13, Laws of Florida,
which mandated that most opioid prescriptions for acute pain be limited to
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a 3-day supply (Florida Department of Health, 2018). Only under special
circumstances can a practitioner increase the opioid prescription to a 7-day
supply.
Model effectiveness
Florida legislation 2018-13, combined with their Prescription Drug
Monitoring Program (PDMP), have worked together to achieve modest
decreases in opioid prescribing and use in the state of Florida (Rutkow et
al., 2015). Florida’s PDMP is similar to that of Michigan’s drug monitoring
program, the Michigan Automated Prescription System (MAPS). Florida’s
effort to end the opioid epidemic can be similarly compared with
Michigan’s as they utilize similar instruments to enforce their legislation.
Arizona
The opioid epidemic has also had a great impact on the state of
Arizona. According to the National Institute on Drug Abuse (2019), “Since
2013, opioid-involved deaths rose 76 percent in Arizona, with 928 deaths
reported in 2017.”To combat their opioid epidemic, Arizona enacted Senate
Bill 1001 Article 4. 32-3248 regarding controlled substances that limit the
initial prescription for a patient for a schedule II-controlled substance that
is an opioid to not more than a five-day supply (Chapter 0001—531S - S
Ver of SB1001, 2018). Arizona takes their fight against opioid overdose one
step further. The Arizona opioid laws place a 90 MME/day dosage limit on
the strength of opioid prescriptions.
Model effectiveness
Since the passing of the Arizona Epidemic Act in 2018, Governor
Doug Ducey has reported a 13% decline in the number of filled
opioid prescriptions over two years. The Governor has also reported a
95% decrease in the number of opioid naive patients given an opioid
prescription (Office of the Governor, 2019). Recognition for the decreases
in prescription opioid use can be directed at the mandated prescription
limits as well as toward Arizona’s Prescription Monitoring Program (PMP).
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Arizona’s PMP is similar to Florida’s PDMP and Michigan’s MAPS. These
systems are designed to assist providers in opioid drug monitoring, and they
further assist in displaying the necessity for prescription limitations.
Alternative Opioid Crisis Mitigation Models
Mandating prescription limits for opioids and utilizing opioid drug
monitoring systems are just one model that US states have adopted to
mitigate their opioid issues. It is imperative for these states to research what
certain states have been implementing other than the prescription limits
to compare and contrast benefits and opioid overdose/death outcomes.
Unfortunately, there is currently not one cure-all solution to the opioid
epidemic, and a combination of solutions and models might be the best
available option.
California
The state of California has both similarities and differences with their
model to curb their opioid epidemic. The state of California does not place
any prescription limits on opioid medication prescribers. California has
enacted Senate Bill 888 (amending Section 11158.1 of the Health and Safety
Code) that extends the requirement for a prescriber to discuss the risks
associated with opioids to any adult patients before issuing the first opioid
prescription (C.A.Legis. Assem, 2019). While Senate Bill 888 does not
involve prescription limitations, it is similar to that of Michigan’s PA 250
of 2017 requiring a prescriber to discuss substance abuse disorder services
before prescribing opioid medication.
California’s model has unique proposed legislative features including:
AB-2789, AB 362 and AB 1468. AB-2789 will mandate the prescribers to
utilize electronic prescriptions starting in 2022 to improve the Californian
opioid database (CURES) (C.A. Legis. Assem, 2018). AB 362 will authorize
San Francisco to operate safe injection sites for users of dangerous drugs
including opioids (C.A. Legis. Assem, 2019). AB 1468 would charge opioid
makers to fund opioid prevention and rehabilitation programs in the state
of California (C.A. Legis. Assem, 2019). AB- 2789, AB 362 and AB 1468
are all progressive legislation that have arguments for and against the ability
to make a positive impact on the opioid epidemic in California.
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New York
Opioid laws designed to curb the epidemic in the state of New York
are similar to that of Michigan’s opioid laws. In 2016, New York passed
legislation that limits prescriptions of opioids to seven days upon initial
consultation or treatment of acute pain. New York government has taken
action to take opioid laws one step further. According to the New York
State Department of Health (2019), “Article 20-D of New York State Tax
Law establishes an excise tax on the sale of opioids. In compliance with
the Opioid Tax, each registrant (such as a manufacturer, wholesaler, or
outsourcing facility) shall provide a report to the Department of Health
detailing all opioids sold into or within New York State.” The opioid tax
legislation has both support for and against the legislation.
Model Effectiveness
Electronic prescriptions, opioid safe injection sites, and opioid taxes are
just a few in a long list of potential solutions for the opioid epidemic. The
opioid tax legislation in particular has strong arguments for and against its
potential for success in reducing opioid use. According to Kaiser Health
News, proponents of the opioid tax argue that the majority of people who
abuse these drugs lack access to the care they need (Bartolone, 2017). Tax
revenue generated from the opioid tax could go to funding the access to
care for opioid abuse treatments. Those against the idea of an opioid tax
being beneficial to end the opioidepidemic argue that the tax will be paid
for by insurance companies through increased premiums for everyone, not
just opioid consumers.
Limitations of Research
2017 PA 251 and other state prescription supply limitation legislation
currently has inadequate published outcome data that is accessible to the
general public. It is difficult to comprehend which piece of legislation, if
any, has had a positive or negative effect on the opioid epidemic in the state
of Michigan. LARA and Michigan DHHS could work together with large
Michigan health systems to collect and publish data and outcomes involving
specific opioid legislation. Difficulties and confusion may arise within
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legislation like 2017 PA 251 if the state government does not know which
legislation is helping and which legislation is hurting the fight to end the
opioid epidemic.
Conclusions and Future Implications
The opioid epidemic does not discriminate. It has had effects on
all individuals no matter their age, race, ethnicity, gender or geographic
location. Opioid prescription limitations, including 2017 PA 251 enacted
in Michigan, are a step in the right direction to finding the solution to the
epidemic. States in the United States have chosen similar yet also different
models to curb their opioid issues. States must stay in communication with
each other to share their data, solutions and potential recommendations for
model improvements. Healthcare executives and administrators will play an
important role in working with state legislators and health departments to
maintain and enhance action against this epidemic.
Fortunately, America as a nation has achieved bipartisan support for
legislation aimed to end the opioid epidemic. President Trump signed
bipartisan bill H.R.6 – Support for Patients and Communities Act into
law on October 24th, 2018. According to Davis (2019), “The Support for
Patients and Communities Act is intended to increase access to evidencebased treatment and follow-up care, particularly for pregnant women,
children, people in rural areas, and people in recovery from an SUD.” The
federal and state governments must dissolve political party lines and work
together to find a lasting solution to the nation’s opioid epidemic.

62

Michigan Opioid Legislation - Act No. 251
References
2017-SCB-0274.pdf. (n.d.). Retrieved from http://www.legislature.
mi.gov/documents/2017- 2018/billconcurred/Senate/pdf/2017SCB-0274.pdf
Act No. 251 Public Acts of 2017, State of Michigan 99th Legislature
(2017). Retrieved January 19, 2019, from file:///C:/Users/nicki/
Documents/GVSU%20WINTER/Winter%202019/PA%20
631/2017-PA- 0251.pdf
Affairs (ASPA), A. S. of P. (2017, December 21). HHS.gov/Opioids: The
prescription drug & heroin overdose epidemic [Text]. Retrieved
January 19, 2019, from https://www.hhs.gov/opioids/
Athena Health (2019). Infographic: State-by-state breakdown of opioid
regulations. (2016, November 17). Retrieved October 20, 2019,
from AthenaInsight website: https://www.athenahealth.com/
insight/infographic-opioid-regulations-state-by-state
Bartolone, P. (2017, April 14). Can we tax away the opioid crisis? Retrieved
October 29, 2019, from Kaiser Health News website: https://khn.
org/news/can-we-tax-away-the-opioid-crisis/
C.A. Legis. Assem. No. 362 Sess. 2019-2020 (2019)
C.A. Legis. Assem. No. 888 Sess. 2019-2020 (2019)
C.A. Legis. Assem. No. 1468 Sess. 2019-2020 (2019)
C.A. Legis. Assem. No. 2789 Sess. 2017-2018 (2018)
CDC Guideline for Prescribing Opioids for Chronic Pain — United States,
2016. (2016). MMWR. Recommendations and Reports, 65. https://doi.
org/10.15585/mmwr.rr6501e1er
Chapter 0001—531S - S Ver of SB1001. (2018). Retrieved October 21,
2019, from https://www.azleg.gov/legtext/53leg/1S/laws/0001.
htm
Davis, C. S. (2019). The support for patients and communities act—what
will it mean for the opioid- overdose crisis? New England Journal of
Medicine, 380(1), 3–5. https://doi.org/10.1056/NEJMp1813961
Dineen, K. K., & DuBois, J. M. (2016). Between a rock and a hard place:
can physicians prescribe opioids to treat pain adequately while
avoiding legal sanction? American Journal of Law & Medicine, 42(1),
7–52. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5494184/
63

Keller
Florida Department of Health. (2018). Take control of controlled
substances • patients. Retrieved October 21, 2019, from http://
www.flhealthsource.gov/FloridaTakeControl/patients
Gavin, K. (2017, July 19). Prescription drug monitoring program (PMDP)
tackles misuse of opioids. Retrieved January 22, 2019, from
https://labblog.uofmhealth.org/rounds/prescription-trackingtackles-misuse-of-opioids-and-other-drugs-but-results-vary
Gavin, K. (2018, November 7). Surgery patients use only 1/4 of the opioids
a surgeon gives -- but the bigger the prescription, the more they
take. Retrieved March 3, 2019, from https://labblog.uofmhealth.
org/rounds/surgery-patients-use-only-14-of-opioids-a-surgeongives- but-bigger-prescription-more-they
Greene, J. (2018, July 29). Opioid laws hit physicians, patients in unintended
ways. Retrieved February 28, 2019, from https://www.crainsdetroit.
com/article/20180729/news/667241/opioid- laws-hit-physicianspatients-in-unintended-ways
Haddad, P. (2018, March 9). New Michigan legislation affecting the
prescribing of controlled substances. Retrieved January 22, 2019,
from http://www.kerr-russell.com/newsroom-news- patrickhaddad-kathleen-westfall-kerr-russell-michigan-detroit-health-carephysicans-opioid- opioids-legislation-controlled-substances-LARA.
html
Hayhurst, C. (2018, October). Moving away from opioid reliance.
Retrieved February 28, 2019, from http://www.apta.org/
PTinMotion/2018/10/Feature/Opioid/
Is safe use of opioids possible? (n.d.). Retrieved January 22, 2019, from
https://www.mayoclinic.org/diseases-conditions/prescriptiondrug-abuse/in-depth/how-to-use- opioids-safely/art-20360373
Johns Hopkins Bloomberg School of Public Health (2018). Health
insurance plans may be fueling opioid epidemic. Retrieved October
21, 2019, from Johns Hopkins Bloomberg School of Public Health
website: https://www.jhsph.edu/news/news-releases/2018/healthinsurance-plans-may-be- fueling-opioid-epidemic.html
National Institute on Drug Abuse (2019, January 29). Overdose death rates.
Retrieved October 29, 2019, from https://www.drugabuse.gov/
related-topics/trends-statistics/overdose-death-rates

64

Michigan Opioid Legislation - Act No. 251
National Institute on Drug Abuse (2018, February 28). Michigan opioid
summary. Retrieved March 5, 2019, from https://www.drugabuse.
gov/drugs-abuse/opioids/opioid-summaries-by- state/michiganopioid-summary
New York State Department of Health (2019). Opioid excise tax. Retrieved
October 25, 2019, from https://www.health.ny.gov/professionals/
narcotic/opioid_excise_tax.htm
Norton, R. (n.d.). Unintended consequences. Retrieved January
19, 2019, from https://www.econlib.org/library/Enc/
UnintendedConsequences.html
Office of the Governor. (2019, August 2). Arizona making progress in fight
against the opioid epidemic. Retrieved October 21, 2019, from
Office of the Arizona Governor website: https://azgovernor.gov/
governor/news/2019/08/arizona-making-progress-fight-againstopioid- epidemic
Opioid Addiction Resources - Get the Facts About Opioids. (n.d.).
Retrieved January 22, 2019, from https://www.michigan.gov/
opioids/0,9238,7-377-88139---,00.html
Ory, M. G. (2018, June 21). What the US can learn from other countries in
dealing with pain and the opioid crisis. Retrieved February 28, 2019,
from http://theconversation.com/what-the-us-can- learn-fromother-countries-in-dealing-with-pain-and-the-opioid-crisis-97491
Policing and the Opioid Crisis: Standards of Care | Bloomberg American
Health Initiative. (n.d.). Retrieved January 19, 2019, from https://
americanhealth.jhu.edu/article/policing-and-opioid- crisisstandards-care
Rutkow, L., Chang, H.-Y., Daubresse, M., Webster, D. W., Stuart, E. A.,
& Alexander, G. C. (2015). Effect of Florida’s prescription drug
monitoring program and pill mill laws on opioid prescribing and
use. JAMA Internal Medicine, 175(10), 1642–1649. https://doi.
org/10.1001/jamainternmed.2015.3931
Understanding the Epidemic | Drug Overdose | CDC Injury Center.
(2018, December 19). Retrieved January 22, 2019, from https://
www.cdc.gov/drugoverdose/epidemic/index.html

65

Keller
Appendix
State of Michigan Legislature (Act No. 251 Only)
Act No. 251
Public Acts of 2017
Approved by the Governor
December 27, 2017
Filed with the Secretary of State
fDecember 27, 2017
EFFECTIVE DATE: March 27, 2018
STATE OF MICHIGAN 99TH LEGISLATURE
REGULAR SESSION OF 2017
Sec. 7333b. (1) Beginning July 1, 2018, if a prescriber is treating a patient for
acute pain, the prescriber shall not prescribe the patient more than a 7-day
supply of an opioid within a 7-day period.
(2) As used in this section, “acute pain” means pain that is the normal,
predicted physiological response to a noxious chemical or a thermal or
mechanical stimulus and is typically associated with invasive procedures,
trauma, and disease and usually lasts for a limited amount of time.
Enacting section 1. This amendatory act takes effect 90 days after the date it
is enacted into law. This act is ordered to take immediate effect.
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